{"entity":{"type":"insider","cik":"0001865796","url":"/insider/0001865796","json_url":"/insider/0001865796.json","name":"Cheng Sohanya Roshan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2022-06-14","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Cheng Sohanya Roshan","source":"filing","n_filings":10,"first_seen":"2022-06-14","last_seen":"2026-05-15"}],"transactions":[{"id":5894466,"accession":"0001193125-26-226652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226652","line_url":"/filing/0001193125-26-226652#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":324.0,"shares_display":"324","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":3078.0,"total_display":"3,078.00","total_whole":"3,078","shares_owned_after":107940.0,"shares_owned_after_display":"107,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":6065957,"accession":"0001865796-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001865796-26-000003","line_url":"/filing/0001865796-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4604.0,"shares_display":"4,604","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":43321.338,"total_display":"43,321.34","total_whole":"43,321","shares_owned_after":107317.0,"shares_owned_after_display":"107,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":4578107,"accession":"0001193125-25-205042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205042","line_url":"/filing/0001193125-25-205042#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":2089.75,"total_display":"2,089.75","total_whole":"2,090","shares_owned_after":35856.0,"shares_owned_after_display":"35,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4460877,"accession":"0000950170-25-034743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034743","line_url":"/filing/0000950170-25-034743#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3445.0,"shares_display":"3,445","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":21669.05,"total_display":"21,669.05","total_whole":"21,669","shares_owned_after":34314.0,"shares_owned_after_display":"34,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2177778,"accession":"0000950170-24-103998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-103998","line_url":"/filing/0000950170-24-103998#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5356.0,"shares_display":"5,356","price_per_share":0.7218,"price_display":"0.72","price_state":"stated","total_value":3865.9608,"total_display":"3,865.96","total_whole":"3,866","shares_owned_after":404051.0,"shares_owned_after_display":"404,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":3151387,"accession":"0000950170-24-025189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025189","line_url":"/filing/0000950170-24-025189#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5109.0,"shares_display":"5,109","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":6130.8,"total_display":"6,130.80","total_whole":"6,131","shares_owned_after":393509.0,"shares_owned_after_display":"393,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":3151385,"accession":"0000950170-24-025189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025189","line_url":"/filing/0000950170-24-025189#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21840.0,"shares_display":"21,840","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":25552.8,"total_display":"25,552.80","total_whole":"25,553","shares_owned_after":398618.0,"shares_owned_after_display":"398,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":8608940,"accession":"0001209191-23-048159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048159","line_url":"/filing/0001209191-23-048159#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7415.0,"shares_display":"7,415","price_per_share":1.3313,"price_display":"1.33","price_state":"stated","total_value":9871.5895,"total_display":"9,871.59","total_whole":"9,872","shares_owned_after":204086.0,"shares_owned_after_display":"204,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8404044,"accession":"0001209191-23-036248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-036248","line_url":"/filing/0001209191-23-036248#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1839.0,"shares_display":"1,839","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":4321.65,"total_display":"4,321.65","total_whole":"4,322","shares_owned_after":211501.0,"shares_owned_after_display":"211,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":7831201,"accession":"0001209191-23-014861","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014861","line_url":"/filing/0001209191-23-014861#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (EVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11239.0,"shares_display":"11,239","price_per_share":3.0292,"price_display":"3.03","price_state":"stated","total_value":34045.1788,"total_display":"34,045.18","total_whole":"34,045","shares_owned_after":210687.0,"shares_owned_after_display":"210,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":6785453,"accession":"0001209191-22-036812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-036812","line_url":"/filing/0001209191-22-036812","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001865796","owner_name":"Cheng Sohanya Roshan","owner_display_name":"Cheng Sohanya Roshan","owner_url":"/insider/0001865796","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1551.0,"shares_display":"1,551","price_per_share":5.206170212765957,"price_display":"5.21","price_state":"stated","total_value":8074.77,"total_display":"8,074.77","total_whole":"8,075","shares_owned_after":89949.0,"shares_owned_after_display":"89,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP & Chief Commercial Officer)","n_filings":10,"first_seen":"2022-06-14","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001865796","retrieved_at":"2026-08-26T23:12:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}